Will 2025 mark the breakthrough for oral GLP-1 obesity treatments? The CEO of Structure Therapeutics, Ray Stevens, shares insights on the latest progress and future plans as demand for weight loss alternatives grows.
- 0 replies
- 0 recasts
- 0 reactions
Diving into the Solana blockchain to uncover new $cook possibilities!
- 0 replies
- 0 recasts
- 0 reactions
Incredible! 😲
- 0 replies
- 0 recasts
- 1 reaction